Rhumatologie

Maintenance of Infliximab Treatment in Ankylosing Spondylitis : results of one-year randomized controlled trial comparing systematic versus on-demand treatment

Arthritis & Rheumatism, Vol. 58, N° 1, January 2008, pp 88-97 Breban M, Ravaud Ph, Claudepierre P, Baron G, Henry Y-D, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X; Wendling D, Fautrel B, Fournié B, Combe B, Gaudin Ph, Jousse S, Mariette X, Baleydier A; Trape G, and Dougados M, for the French Ankylosing Spondylitis Infliximab Network.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.
Rhumatologie

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
Rhumatologie

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis